<DOC>
	<DOCNO>NCT00673933</DOCNO>
	<brief_summary>In multicenter study , patient dark skin acne vulgaris include . The patient receive treatment MAL PDT placebo PDT .</brief_summary>
	<brief_title>Photodynamic Therapy ( PDT ) With Methyl Aminolevulinate ( MAL ) Cream Patients With Skin Type V IV With Acne Vulgaris</brief_title>
	<detailed_description>The treatment period start within 2 week study screen . Patients receive two treatment ( MAL PDT vehicle PDT ) treatment area , 2 week apart , followed-up 4 week last treatment . The total duration study 6-8 week . Methyl aminolevulinate 80 mg/g cream ( MAL cream 8 % ) vehicle apply 1.5 hour illumination ( AktiliteÂ® CL128 ) , total light dose 37 J/cm2</detailed_description>
	<mesh_term>Acne Vulgaris</mesh_term>
	<mesh_term>Aminolevulinic Acid</mesh_term>
	<mesh_term>Methyl 5-aminolevulinate</mesh_term>
	<criteria>1 . Female male patient , age 15 40 year acne vulgaris . 2 . Patients skin type V VI ( Fitzpatrick ) . 3 . Patients two area 8x8 cm2 back include least 5 inflammatory lesion ( papule , pustule , nodule ) . The minimum distance two area least 4 cm . 4 . Patients 2 nodular lesion two area 8x8 cm2 back . 5 . Patients surgically sterile , postmenopausal , abstinent , willing use adequate mean contraception include birth control pill , barrier method spermicide least 14 day prior Day 0 . Patients use birth control pill must use product dose least 3 month must agree stay product dose additional 3 month . 6 . Patients must willing capable follow study instruction extent degree require protocol . 7 . Patients must sign approve informed consent form prior study procedure . 8 . Patients must willing photograph . Patients must willing sign photography consent form . 1 . Known allergy MAL , similar PDT compound , excipients cream . 2 . Participation clinical study either concurrently within last 30 day . 3 . Patients condition situation , , investigator 's opinion , may put patient risk , may confound study result , may interfere patient 's participation study . 4 . Clinically significant sensitivity visible light , porphyria porphyrin sensitivity . 5 . Exposure ultraviolet radiation ( UVB phototherapy ) within last 30 day . 6 . Patients washout period topical treatment acne two treatment area less 14 day . Any topical treatment face area outside two treatment area allow . 7 . Patients washout period oral antibiotic treatment acne less 1 month . 8 . Patients washout period oral isotretinoin le 6 month .</criteria>
	<gender>All</gender>
	<minimum_age>15 Years</minimum_age>
	<maximum_age>40 Years</maximum_age>
	<verification_date>July 2013</verification_date>
</DOC>